TOP2A is overexpressed in various malignancies and is associated with chemotherapy resistance, abnormal cell proliferation, aneuploidy, tumor recurrence, and reduced overall survival (Liu et al., 2019). The gene discussed is TOP2A; the disease is neoplasm.